GAO: Generics Getting Faster Approvals, but FDA Needs Plan to Use Extra GDUFA Funds

Drug Industry Daily
The FDA surpassed many of its performance goals for generic drug applications through 2016, but the agency needs a plan for the user fees collected but not spent in the same year, according to the GAO.

To View This Article:


Subscribe To Drug Industry Daily